Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions

被引:21
作者
Nagai, N [1 ]
Oshita, T [1 ]
Murakami, J [1 ]
Ohama, K [1 ]
机构
[1] Hiroshima Univ, Sch Med, Dept Obstet & Gynecol, Minami Ku, Hiroshima 7348551, Japan
关键词
telomerase; TRAP assay; cervical neoplasia;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated telomerase expression in cervical lesions and its diagnostic value for cervical cancer and the precancerous lesions. The subjects were 100 women who underwent cervical biopsy, comprising 16 normal cervix, 61 cervical intraepithelial neoplasia (CIN) and 23 invasive cervical cancer. Telomerase activity was detected by the telomerase repeat amplification protocol using a non-radioisotope system, and quantitated using a DNA image analyzing system. Telomerase was detected at 18.8% (3/16) in normal cervix, 32.0% (8/25) in CW I, 50.0% (3/6) in CIN LI, 60.0% (18/30) in CIN III, and 91.3% (21/23) in invasive cervical cancer. Semiquantitation of telomerase activity was significantly higher in the subjects with invasive cancer than in those with CIN or a normal cervix (p<0.05). However, telomerase activity was not significantly different between the grades of GIN. Telomerase was detected in subjects with GIN, suggesting that telomerase expression is an early event in cervical carcinogenesis. Quantitation of telomerase activity may be helpful for the diagnosis of cervical cancer.
引用
收藏
页码:325 / 328
页数:4
相关论文
共 24 条
[1]  
Anderson S, 1997, AM J PATHOL, V151, P25
[2]   TELOMERASE ACTIVITY IN NORMAL LEUKOCYTES AND IN HEMATOLOGIC MALIGNANCIES [J].
COUNTER, CM ;
GUPTA, J ;
HARLEY, CB ;
LEBER, B ;
BACCHETTI, S .
BLOOD, 1995, 85 (09) :2315-2320
[3]  
CRUM CP, 1986, AM J PATHOL, V123, P174
[4]   THE RNA COMPONENT OF HUMAN TELOMERASE [J].
FENG, JL ;
FUNK, WD ;
WANG, SS ;
WEINRICH, SL ;
AVILION, AA ;
CHIU, CP ;
ADAMS, RR ;
CHANG, E ;
ALLSOPP, RC ;
YU, JH ;
LE, SY ;
WEST, MD ;
HARLEY, CB ;
ANDREWS, WH ;
GREIDER, CW ;
VILLEPONTEAU, B .
SCIENCE, 1995, 269 (5228) :1236-1241
[5]   Telomerase activity in human gynaecological malignancies [J].
Gorham, H ;
Yoshida, K ;
Sugino, T ;
Marsh, G ;
Manek, S ;
Charnock, M ;
Tarin, D ;
Goodison, S .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (06) :501-504
[6]   A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol [J].
Hirose, M ;
AbeHashimoto, J ;
Ogura, K ;
Tahara, H ;
Ide, T ;
Yoshimura, T .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (06) :337-344
[7]  
Hiyama E, 1996, INT J ONCOL, V9, P453
[8]  
*JAP SOC OBST GYN, 1997, GEN RUL CLIN PATH MA
[9]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[10]   Telomerase activation by the E6 gene product of human papillomavirus type 16 [J].
Klingelhutz, AJ ;
Foster, SA ;
McDougall, JK .
NATURE, 1996, 380 (6569) :79-82